2 news items
Paladin Labs Announces Approval of WAKIX® (pitolisant hydrochloride tablets) For Use in Pediatric Patients in Canada
ENDPQ
28 Mar 24
Francesco, Vice President & General Manager of Paladin Labs Inc. "Paladin Labs is committed to offering innovative treatment options
Endo Launches Ibuprofen-Famotidine Tablets, Generic Version of DUEXIS®
ENDPQ
26 Mar 24
(OTC:ENDPQ) is a specialty pharmaceutical company committed to helping everyone we serve live their best
- Prev
- 1
- Next